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Background: Acute renal failure is a dose-limiting
factor of cisplatin chemotherapy. Here, we show the
protective effect of ozone oxidative preconditioning
against cisplatin-induced renal dysfunction in rats.
Ozone oxidative preconditioning is a prophylactic
approach, which favors the antioxidant 
/pro-oxidant
balance for preservation of the cell redox state by
increasing antioxidant endogenous systems in var-
ious in vivo and in vitro experimental models.
Aims: To analyze the protective role of ozone oxida-
tive preconditioning against cisplatin-induced ne-
phrotoxicity.
Methods: Male Sprague 
/Dawley rats were pretreated
with 15 intrarectal applications of ozone/oxygen
mixture at 0.36, 0.72, 1.1, 1.8 and 2.5 mg/kg before
cisplatin intraperitoneal injection (6 mg/kg). Serum
and kidneys were extracted and analyzed 5 days after
cisplatin treatment for determinations of the renal
content of glutathione, thiobarbituric acid-reactive
substances, renal concentration and enzymatic activ-
ities of catalase, superoxide dismutase and glu-
tathione peroxidase.
Results: Ozone pretreatment prevented the increase
in serum creatinine levels, the glutathione depletion
and the inhibition of superoxide dismutase, catalase
and glutathione peroxidase activities induced by
cisplatin in the rat kidney. Also, the renal content
of thiobarbituric acid-reactive substances was de-
creased by ozone therapy. These protective effects
of ozone were dose dependent.
Conclusions: Intrarectal ozone therapy prevented
effectively the renal antioxidant unbalance induced
by cisplatin treatment.
Key words: Ozone oxidative preconditioning, Cisplatin-
induced nephrotoxicity, Antioxidant defenses, Lipid perox-
idation
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Introduction
Cisplatin (CDDP) is an effective chemotherapeutic
agent commonly used in the treatment of a variety of
solid-organs cancers, including those of the head,
neck, testis, ovary and breast.
1 Unfortunately,
28 /36% of patients receiving a dose of CDDP
develop acute renal failure.
1 Therefore, its pathogen-
esis has been the focus of many investigations, which
have shown that acute renal failure induced by CDDP
is accompanied by the reduced renal blood flow
associated with increased renal vascular resistance
and histological damage to the proximal tubular
cells.
2,3
Additionally, evidence is available that the cellular
events in CDDP-mediated nephrotoxicity, including
apoptosis induction, decreased protein synthesis,
membrane peroxidation, mitochondrial dysfunction
and DNA injury, are a consequence of reactive
oxygen species (ROS) generation, which produces
oxidative renal damage.
4 9 Thus, administration of
CDDP causes depletion of renal reduced glutathione
(GSH) and an increase of lipid peroxidation accom-
panied with a decrease in the activity of enzymes that
protect against lipid peroxidation in the kidney, such
as superoxide dismutase (SOD), catalase (CAT) and
glutathione peroxidase (GSH-Px).
4 9
In agreement with this, administration of known
antioxidant molecules like vitamin E, ascorbic acid,
ebselen, lipoic acid, GSH and its esters, CAT and the
SOD mimetic orgotein, among others, have shown
nephroprotective effects in CDDP-treated rats.
10 16
Recently it was reported that oxidative precondi-
tioning with ozone prevents renal damage in rats
submitted to warm ischemia,
17 suggesting that oxida-
tive preconditioning with ozone may provide a
prophylactic approach for minimizing renal damage
before transplantation, which is also mediated by
ROS production. Taking into account these findings,
we decided to evaluate the role of ozone oxidative
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13preconditioning in CDDP-induced acute renal da-
mage in rats and to determine its potential protective
effects on some important constituents of the anti-
oxidant system in the kidney.
Materials and methods
Chemicals
Serum creatinine (Cr) was measured spectrophoto-
metrically with the Cr assay kits purchased from
Biological Products Enterprise ‘Carlos J Finlay’
(Havana, Cuba). All reagents used in determinations
of GSH, SOD, CAT, GSH-Px, thiobarbituric acid-
reactive substances (TBARS) and cisplatin were
purchased from Sigma Chemicals (St Louis, MO,
USA). Other reagents of analytical grade were ob-
tained from normal commercial sources.
Animals
Male Sprague /Dawley rats (200 /250 g) were ob-
tained from the National Center for Laboratory
Animal Production (CENPALAB, Havana Cuba). The
animals were housed under a 12 h light /dark cycle
with room temperature maintained at 258C, humidity
at 60% and food and water available ad libitum. The
experiments were conducted in accordance with the
ethical guidelines for investigations in laboratory
animals and were approved by the Ethical Committee
for Animal Experimentation of the National Center for
Scientific Research, Havana, Cuba.
Experimental design
Ozone (O3) was generated by an OZOMED 01
equipment manufactured by the Ozone Research
Center (Cuba). O3 obtained from medical-grade
oxygen (O2) was used immediately. The O3 concen-
tration was measured using an ultraviolet spectro-
photometer at 254 nm. An O3/O2 mixture was
administered by rectal insufflations (i.r.) at doses of
0.36, 0.72, 1.1, 1.8 and 2.5 mg/kg. The volume of
insufflated mixture was approximately 9 ml. Oxida-
tive preconditioning was performed with 15 applica-
tions (one daily) of the O3/O2 mixture. CDDP
was applied 1 day after the 15 applications of the
O3/O2 mixture by an intraperitoneal injection (6 mg/
kg). Five days after CDDP injection, animals were
sacrificed by asphyxia in ether.
The animals were divided into 10 groups of seven
rats each: (1) non-treated control rats, (2) rats treated
with O2, (3) rats treated with O3/O2 mixture (1.1 mg/
kg), (4) rats treated with O2  /CDDP, (5) rats treated
only with CDDP, (6) rats treated with O3/O2 mixture
(10 mg of ozone/ml of mixture at a dose of 0.36 mg/
kg)  /CDDP, (7) rats treated with O3/O2 mixture
(20 mg of ozone/ml of mixture at a dose of 0.72
mg/kg)  /CDDP, (8) rats treated with O3/O2 mixture
(30 mg of ozone/ml of mixture at a dose of 1.1 mg/
kg)  /CDDP, (9) rats treated with O3/O2 mixture
(50 mg of ozone/ml of mixture at a dose of 1.8 mg/
kg)  /CDDP, and (10) rats treated with O3 O2 mixture
(70 mg of ozone/ml of mixture at a dose of 2.5 mg/
kg)  /CDDP. Rats were killed 5 days after CDDP
injection by an overdose of ether. The blood was
collected and serum was separated by centrifugation
for Cr analysis. The kidneys were dissected and
immediately frozen at  /208C until analysis could be
completed.
Kidney homogenates were obtained using a tissue
homogenator (Ultraturrax T-25 Polytron) at 48C. The
homogenates were prepared by using a 100 mM KCl
buffer (pH 7) containing 0.3 mM ethylenediamine
tetraacetic acid (1:10 w/v) for GSH, TBARS, GSH-Px
and SOD determinations (Buffer 1). The homoge-
nates were spun down with a centrifuge at 600 /g
for 60 min at 48C. The supernatants were taken for
biochemical determinations.
Kidney homogenates for CAT enzymatic assay
were carried out using 50 mM phosphate buffer
(pH 7) containing 1% Triton X-100 (1:9 w/v) (Buffer
2). The homogenates were centrifuged at 600 /g for
60 min at 48C and the supernatants were used for the
CAT assay.
Determination of GSH
GSH was determined by a slightly modified version
of the method of Beutler et al.,
18 using a spectro-
photometer. One milliliter of the kidney homogenate,
as described earlier, was mixed with 1.5 ml of 5%
metaphosphoric acid and centrifuged at 3000 /g for
10 min at room temperature. Fifty hundred micro-
liters of this acidic supernatant was mixed with 2 ml
of 0.2 M phosphate buffer and 0.25 ml of 0.04% 5,
5?-dithio-bis(-2-nitrobenzoic acid). Absorbance of the
yellow solution was measured at 412 nm within 10
min. A molar extinction coefficient of 13.6 M/cm that
describes the formation of the thiolate anion by the
reaction of sulfhydryl groups with 5,5?-dithio-bis-2-
nitrobenzoic acid at 412 nm was used to quantify
GSH.
Determination of SOD activity
Enzymatic activity of SOD was determined by a
modified version of the method of Minami and
Yoshikawa.
19 Fifty microliters of the kidney homo-
genate was mixed with 450 ml of cold deionized
water, 125 ml of chloroform and 250 ml of ethanol.
The mixture was centrifuged at 8000 /g for 2 min at
48C. Fifty hundred microliters of the extract was
added to the reaction mixture containing 500 mlo f
72.4 mM Tris cacodylate buffer with 3.5 mM diethy-
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100 and 250 ml of 0.9 mM nitro blue tetrazolium. The
reaction mixture was incubated for 5 min at 378C
before adding 10 ml of 9 mM pyrogallol (dissolved in
10 mM hydrochloric acid), and then it was incubated
for exactly 5 min at 378C. The reaction was stopped
with the addition of 300 ml of 2 M formic buffer
(pH 3.5) containing 16% Triton-X 100. The absor-
bance was measured at 540 nm in the spectro-
photometer. One unit of SOD enzymatic activity is
equal to the amount of enzyme that diminishes the
initial absorbance of nitro blue tetrazolium by 50%.
Determination of CAT activity
CAT was determined according to the method of
Evans and Diplock.
20 Kidney homogenate was di-
luted with Buffer 2, as already described, to obtain an
adequate dilution of the enzyme. Then, 2 ml of the
enzyme dilution were added to the cuvette and
mixed with 1 ml of 30 mM H2O2, and then the
absorbance was measured at 240 nm, for 30 sec, in
the spectrophotometer. Initial absorbance of the
reaction mixture must be around 0.5. The enzyme
activity is expressed as the first-order constant
that describes the decomposition of H2O2 at room
temperature.
Determination of GSH-Px activity
Enzymatic activity of GSH-Px was measured using a
modified version of the method of Thonson et al.
21
All reaction mixtures were dissolved in 20 mM
sodium phosphate buffer containing 6 mM ethylene-
diamine tetraacetic acid (pH 7.0). The reaction
mixture consisted of 98.8 ml of phosphate buffer,
700 ml of 2.86 mM GSH, 100 ml of 1 mM sodium azide,
100 ml of 1 mM NADPH and 4.2 ml of GSH reductase
(0.5 u). Then, 10 ml of the tissue homogenate super-
natant were added to the reaction mixture and
incubated at room temperature for 10 /15 min.
Afterward, 10 mlo f3 0m Mt-butyl hydroperoxide
(dissolved in bidistilled water) was added to the
reaction mixture and measured at 340 nm for 7 min in
the spectrophotometer. A molar extinction coefficient
of 6.22 /10
3 M/cm was used to determine the
activity of GSH-Px. The enzyme activity is expressed
as international units of enzymatic activity per milli-
gram of protein. International units are expressed as
micromoles of hydroperoxides transformed per min-
ute per milliliter of enzyme.
Lipid peroxidation assay
This assay was used to estimate TBARS levels as
described by Ohkawa et al.
22 Two hundred milliliters
of tissue homogenate supernatant were added to 100
ml of sodium dodecyl sulfate, 750 ml of 20% acetic acid
(pH 3.5), 750 ml of 0.6% thiobarbituric acid and 300 ml
of distilled water, and were incubated at 958C for 60
min. The samples were allowed to cool at room
temperature. Then 2.5 ml of butanol:pyridine (15:1)
and 500 ml of distilled water were added, vortexed,
and centrifuged at 2000 /g for 15 min. The absor-
bance of three ml of the colored layer was measured
at 532 nm spectrophotometrically using 1,1,3,3-
tetraethoxypropane as standard.
Protein assay
Protein concentrations were determined by the
method of Lowry
23 using bovine serum albumin as
standard.
Histopathological assessment of renal damage
The left kidneys were quickly removed and fixed in
10% formaldehyde. Tissues were embedded in par-
affin, sectioned at 3 mm, stained with hematoxylin
and eosin (H/E) and evaluated by light microscopy.
Statistical analysis
Data are expressed as means9 /standard error of the
mean and analyzed statistically using one-way ana-
lysis of variance followed by the Duncan multiple
range test for serum Cr determinations, whereas the
Kruskall /Wallis test followed by the Mann /Whitney
test was applied for the rest of the markers. The 0.05
level of probability was used as statistical signifi-
cance.
Results
Loss of body weight in all animals was observed 5
days after CDDP injection. The mean reduction in
body weight was approximately 16 g, which repre-
sents 8% of the initial body weight. This effect on
body weight was not reversed in animal groups
under O3 therapy with mixtures of O3/O2 adminis-
tered by rectal insufflation.
The levels of Cr in the blood serum of control and
experimental rats are presented in Table 1. After
CDDP injection, Cr levels increased about four-fold at
day 5 with respect to non-treated controls. However,
there were no significant differences in the concen-
trations of Cr in rat serum between the non-treated
controls and those only treated with O2. No signifi-
cant differences in Cr levels were found between the
group treated with CDDP alone and the other one
with CDDP  /O2. In contrast, oxidative precondition-
ing with O3/O2 mixture during 15 days at doses of
0.72 and 1.1 mg/kg but not 0.36 mg/kg induced a
remarkable decrease in Cr levels in serum with
Ozone preconditioning in nephrotoxicity
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doses of 1.8 and 2.5 mg/kg did not significantly
decrease Cr (Table 1).
The concentration of renal reduced GSH was
significantly decreased (58% of non-treated control)
in CDDP-treated rats. Ozone therapy (0.72, 1.1, 1.8
and 2.5 mg/kg i.r.) prevented renal GSH depletion
induced by CDDP. This effect was greater at doses of
0.72 and 1.1 mg/kg (pB/0.01). The lowest dose of O3
(0.36 mg/kg) was not effective in the prevention of
GSH depletion.(Table 1).
The kidney TBARS content used as a measure of
lipid peroxidation was significantly increased in rats
treated with CDDP alone, as compared with non-
treated controls. Oxidative preconditioning with
O3/O2 mixture during 15 days induced significant
decrease in TBARS content at O3 doses of 0.72 mg/kg
(pB/0.05), 1.1 mg/kg (pB/0.001), 1.8 mg/kg
(pB/0.001) and 2.5 mg/kg (pB/0.01) as compared
with CDDP alone. The lower O3 dose (0.36 mg/kg)
did not induce any significant change on renal TBARS
content. The data indicate that the induction of lipid
peroxidation made by CDDP in the kidney is
attenuated by O3 therapy in a dose-dependent
manner (Table 1).
SOD activity in the kidney was significantly de-
creased (71% of non-treated control) in CDDP-treated
rats (Table 1). Pretreatment with O3/O2 mixtures
(0.72 and 1.1 mg/kg) significantly increased
(pB/0.01) SOD activity in CDDP-treated animals,
which was close to values of non-treated control.
However, the lower O3 dose (0.36 mg/kg) and the
greater ones (1.8 and 2.5 mg/kg) did not avoid the
decreasing in SOD activity. On the contrary, the
greatest O3 tested dose (2.5 mg/kg) induced a
remarkable and significant decrease (pB/0.01) of
SOD activity (3.059 /0.48) versus (6.29 /0.9) in the
CDDP-treated control, which provides evidence of its
deleterious effect on this antioxidant enzyme.
CAT activity in the rat kidney was significantly
decreased (63% of non-treated control) in CDDP-
treated rats. Pretreatment with O3 (0.72, 1.1,1.8 and
2.5 mg/kg, but not 0.36 mg/kg) significantly pre-
vented (pB/0.05) the inhibitory effect of CDDP on
CAT activity (Table 1).
GSH-Px activity in the kidney was significantly
decreased (82% of non-treated control) in CDDP-
treated rats. O3 pretreatment (0.72 and 1.1 mg/kg)
significantly increased, almost twice (pB/0.01), the
GSH-Px activity with respect to both CDDP-treated
control rats and non-treated rats. The greater O3
doses (1.8 and 2.5 mg/kg) induced a minor increase
on the enzyme activity (Table 1).
The histopathological changes in the kidney tissue
are reported in Fig. 1. Non-treated rats exhibited
cellular tumefaction, probably due to the type of
euthanasia (asphyxia by ether) (Fig. 1A). Rats treated
with CDDP alone revealed intense tubular necrosis,
desquamation of renal tubular cells, and cast
formation in the lumen, as reported in previous
works (Fig. 1B). O3-treated rats with 1.1 mg/kg
showed a moderate cellular tumefaction, revealing
no significant differences between them and non-
treated rats. At greater doses of 1.8 and 2.5 mg/kg
doses, histopathological changes in renal tissue were
quite similar to those present in CDDP-treated rats.
O3 oxidative preconditioning provided significant
protection against CDDP-induced nephrotoxicity,
and the majority of the treated animals showed no
significant histopathological alterations (Fig. 1C).
Discussion
The aim of this work was to determine the effect of
O3 oxidative preconditioning on the severity of
CDDP-induced nephrotoxicity. In the present study,
CDDP-induced acute kidney damage was character-
Table 1. Biochemical determinations in experimental groups
Experimental groups Serum Cr
levels (mM)
GSH (nmol/mg
of protein)
TBARS (nmol/
mg of protein)
SOD (SOD units/
mg of protein)
CAT(k15/gof
wet tissue)
GSH-Px (IU/mg
of protein)
Non-treated control 67.99 /11.73* 9.39 /0.90* 0.259 /0.014* 8.79 /1.15* 6.89 /0.39 * 6.09 /0.25*
Oxygen-treated control 70.69 /6.61* 8.99 /0.96
* 0.269 /0.012
* 8.89 /1.26* 6.79 /0.63* 6.19 /0.14*
Ozone-treated control 69.29 /7.61* 8.59 /0.47* 0.319 /0.034* 8.69 /1.72* 6.79 /1.56* 6.19 /0.14*
CDDP control 280.69 /45.05 5.49 /0.76 0.639 /0.12 6.29 /0.9 4.39 /0.74 5.39 /0.69
O2 /CDDP control 288.49 /44.03 4.99 /0.81 0.559 /0.029 6.69 /0.94 4.39 /0.49 5.59 /0.55
O3 (0.36 mg/kg)  /CDDP 294.99 /47.70 6.69 /1.34 0.549 /0.077 6.89 /1.23 5.29 /0.79 5.99 /0.98
O3 (0.72 mg/kg)  /CDDP 106.09 /29.78* 12.39 /1.17* 0.489 /0.049 9.19 /0.81* 5.59 /0.67* 10.59 /1.03*
O3 (1.1 mg/kg)  /CDDP 130.49 /30.41* 13.49 /2.7* 0.299 /0.062* 9.19 /1.01* 6.09 /0.54* 7.99 /1.32*
O3 (1.8 mg/kg)  /CDDP 288.49 /47.81 10.99 /1.57* 0.229 /0.03* 6.19 /0.9 5.99 /0.57* 5.89 /0.89 *
O3 (2.5 mg/kg)  /CDDP 392.99 /47.56 10.69 /1.76 * 0.289 /0.033* 3.09 /0.48* 6.19 /64* 5.79 /0.62 *
Data presented as (mean9 /standard error of the mean. Serum Cr was measured with the Cr assay kits (Biological Products Enterprise ‘Carlos J
Finlay’, Havana, Cuba). GSH was determined by the method of Beutler et al.
18 Enzymatic activity of SOD was determined by a version of the
method of Minami and Yoshikawa
19 (one unit of SOD enzymatic activity is equal to the amount of enzyme that diminishes the initial absorbance
of nitro blue tetrazolium by 50%). CAT was determined according to the method of Evans and Diplock
20 (the enzyme activity is expressed as the
first-order constant that describes the decomposition of hydrogen peroxide at room temperature). Enzymatic activity of GSH-Px was measured
using a modified version of the method of Thonson et al.
21 (the enzyme activity is expressed as international units of enzymatic activity per
milligram of protein). TBARS levels were estimated by Ohkawa et al.
22 Protein concentrations were determined by the method of Lowry.
23 *
Significant differences with CDDP-treated control groups (pB/0.05).
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in the kidney GSH content and GSH-Px, SOD and
CAT activities, and an increase in TBARS production
in comparison with the non-treated controls. Histo-
pathological examination of the kidneys of CDDP-
treated rats revealed marked tubular necrosis and
desquamation of renal tubular cells. These results are
in accordance with previous reports.
4 16
The mechanisms underlying CDDP-induced ne-
phrotoxicity have not been fully elucidated. Several
investigators have shown that ROS are closely related
to the nephrotoxicity induced by CDDP.
5 7,14 It has
also been reported that the inordinate generation of
ROS contributes to the initiation and/or maintenance
of acute tubular necrosis.
5 7,14 Indeed, several anti-
oxidants such as SOD, ebselen, vitamin E and vitamin
C are reported to attenuate cisplatin-induced renal
toxicity.
10 16 Several reports demonstrate different
mechanisms involved in the CDDP-induced nephro-
toxicity including protein kinase C activation,
24
elevation of caspase-3 activity resulting in renal cell
apoptosis,
8 enhancement of intrarenal synthesis of
thromboxane A2
25 and dyslipidemia.
26
Oxidative preconditioning is analogous to other
phenomena such as ischemic preconditioning,
27
thermal preconditioning
28 and chemical precondi-
tioning.
29 All of these processes have in common that
a repeated and controlled stress is able to protect
against a prolonged and severe stress.
Intrarectal O3 therapy has conferred protection
against hepatic ischemia/reperfusion injury by the
adenosine accumulation and by blocking the
xanthine/xanthine oxidase pathway, decreasing
ROS generation after reperfusion.
30 32 Recently, it
was demonstrated that intrarectal application of an
O3/O2 mixture reduced ROS by stimulation and/or
preservation of the endogenous antioxidant systems
in experimental models of liver and renal ischemia-
reperfusion, respectively.
30 32 Also, there is evidence
of an increase in the activity of antioxidant enzymes
such as SOD and GSH-Px and a decrease of
malondialdehyde after O3 preconditioning in patients
with cardiopathy and in rats suffering ischemia/
reperfusion damage.
17,33
Our experimental results clearly demonstrate that
oxidative preconditioning with O3 exerts protective
effects in CDDP-induced acute nephrotoxicity in rats.
Furthermore, the data provide strong evidence that
i.r. O3 therapy effectively prevented a decrease in the
renal antioxidant defense system and certainly
avoided the deleterious effect of CDDP on it.
FIG. 1. Histopathological changes in rat kidneys after CDDP administration (6 mg/kg) and under i.r. O3 therapy. (A) Light
micrograph of rat kidneys from the control group. Slight cellular tumefaction ascribed to the type of euthanasia (asphyxia by
ether). H/E stain, /100. (B) Light micrograph from a CDDP-treated rat. Note the widespread tubular necrosis and cast
formation in the tubular lumen. H/E stain, /100. (C) Light micrograph of a rat kidney, which received 15 applications of O3 (1.1
mg/kg) by rectal insufﬂation before CDDP injection. Moderate cellular tumefaction was observed. H/E stain, /100.
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vented GSH depletion and the decrease of SOD, CAT
and GSH-Px activities induced by CDDP in rat
kidney. Also, renal TBARS content was diminished
by O3 therapy. These protective effects of O3 were
dose dependent. The lowest dose of 0.36 mg/kg did
not induce any significant change in the former
antioxidant markers. In contrast, the doses of 0.72
and 1.1 mg/kg significantly reduced serum Cr and
TBARS levels and preserved some constituents of the
antioxidant defense, such as GSH content, SOD, CAT
and GSH-PX activities, which were levels close to or
even greater than those of non treated controls
(Table 1).
Furthermore, the preservation of renal SOD, CAT
and GSH-PX activities by O3 pretreatment at lower
doses (0.72 and 1.1 mg/kg) shows that this agent can
protect these enzymes even 5 days after CDDP
administration. Neither significant change of GSH
and TBARS renal content nor statistic differences in
CAT activity were found at the greater ozone doses of
1.8 and 2.5 mg/kg as compared with that of 1.1 mg/
kg, which indicates that the ‘plateau effect’ in the
dose /response curves was reached.
Induction of CAT, SOD, and GSH-Px by O3 therapy
is probably due to hydrogen peroxide produced as
result of O3 decomposition. Hydrogen peroxide has
been shown to be one of the major intermediates of
O3 decomposition along with oxygen radicals (OH+
and O2
+).
In contrast, the greatest O3 dose (2.5 mg/kg)
induced a marked and significant decrease of SOD
activity (3.059 /0.48 u/mg of protein) as compared
with non-treated controls (8.729 /1.15 u/mg of pro-
tein), which reveals deleterious effects of ozone
treatment on this enzyme, which is probably due to
SOD inactivation by H2O2 at greater concentrations
as it has been demonstrated by Marklund.
34 This
author suggested that inactivation of Cu Zn SOD by
H2O2 appears to be due to a Fenton-type reaction of
H2O2 with Cu, forming a reactive intermediate that
destroys an essential liganding histidine residue of
the enzyme. Whiteside and Hassan also demon-
strated induction and inactivation of CAT and SOD
by ozone in cultures of Escherichia coli.
35
Furthermore, they showed that an increase in the
activities of CAT and SOD by O3 was due to induction
of the novo enzyme synthesis rather than activation
of pre-existing apoproteins. Thus, the observed
induction of SOD, CAT and GSH-Px in response to
O3 pretreatment provides further evidence that there
is a correlation between antioxidant enzyme bio-
synthesis and O3 exposure.
Additionally, these authors also showed that the
antioxidant enzymes are subjected in vivo to the
damaging effects of O3 at relatively high doses.
Therefore, in concordance with our results this
observation provides evidence that O3, besides
inducing the biosynthesis of these enzymes, could
also cause inactivation of them by the mechanism
previously explained.
In addition, O3 oxidative preconditioning might
prevent CDDP-induced acute renal failure through
attenuation of renal tubular damage and enhance-
ment of the regenerative response of the damaged
tubular cells. As shown in Fig. 1, animals treated with
i.r. O3 therapy before CDDP recovered the normal
structure of its kidneys 5 days after CDDP adminis-
tration, showing a moderate cellular tumefaction, in
contrast with CDDP-treated rats, which showed
severe acute tubular necrosis.
In conclusion, a single dose of CDDP leads to the
inhibition of renal antioxidant enzyme activity,
depletion of renal GSH levels, increased serum Cr
and enhanced renal lipid peroxidation, which cause
nephrotoxicity. Our results support the evidence that
part of the mechanism of nephrotoxicity in CDDP-
treated rats is related to depletion and inhibition of
the antioxidant system. Therefore, the prevention of
this inhibition in rats protected by i.r. O3 therapy
support the potential use of it at low doses to
ameliorate CDDP-induced renal injury.
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